Page 96 - Human Lyme Neuroborreliosis
P. 96

80 David S. Younger

[34] Ljostad U, Skarpaas T, Mygland A. Clinical usefulness of intrathecal
       antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 2007;
       14:873-876.

[35] Halperin JJ. Nervous system Lyme disease. Handb Clin Neurol 2014;
       121:1473-1483.

[36] Steere AC, Berardi VP, Weeks KE, et al. Evaluation of the intrathecal
       antibody response to Borrelia burgdorferi as a diagnostic test for Lyme
       neuroborreliosis. J Infect Dis 1990; 161:1203-1209.

[37] Sindern E, Malin JP. Phenotypic analysis of cerebrospinal fluid over the
       course of Lyme meningoradiculitis. Acta Cytol 1995; 39:73-75.

[38] Kieslich M, Fiedler A, Driever PH, et al. Lyme borreliosis mimicking
       central nervous system malignancy: the diagnostic pitfall of
       cerebrospinal fluid cytology. Brain Dev 2000; 22:403-406.

[39] Agosta F, Rocca MA, Beneditti B, et al. MR imaging assessment of
       brain and cervical cord damage in patients with neuroborreliosis. AJNR
       Am J Neuroradiol 2006; 27:892-894.

[40] Rigotti DJ, Inglese M, Gonen O. Whole-brain N-acetylaspartate as a
       surrogate marker of neuronal damage in diffuse neurological disorders.
       AJNR Am J Neuroradiol 2007; 28:1843-1849.

[41] Younger DS, Wu WE, Hardy C, Perry N, Gonen O. Lyme
       neuroborreliosis and proton MR spectroscopy: Preliminary results from
       an urban referral center employing strict CDC criteria for case selection.
       Neurology 2012; 78(Suppl1):PO3.246.

[42] Logigian EL, Johnson KA, Kijewski MF, et al. Reversible cerebral
       hypoperfusion in Lyme encephalopathy. Neurology 1997; 49:1661-1670.

[43] Newberg A, Hassan A, Alavi A. Cerebral metabolic changes associated
       with Lyme disease. Nucl Med Commun 2002; 23:773-777.

[44] Fallon BA, Lipkin RB, Corbera KM, et al. Regional cerebral blood flow
       and metabolic rate in persistent Lyme encephalopathy. Arch Gen
       Psychiatry 2009; 66:554-563.

[45] Ferrante MA. Electrodiagnostic studies in motor disorders. Chapter 5.
       In, DS Younger, Ed. Motor Disorders, 3rd edition. David S. Younger
       MD PC: New York, 2013; 83-105.

[46] Maimone D, Villanova M, Stanta G, et al. Detection of Borrelia
       burgdorferi DNA and complement membrane attack complex deposits
       in the sural nerve of a patient with chronic polyneuropathy and tertiary
       Lyme disease. Muscle Nerve 1997; 20:969-975.

[47] Sterman AB, Nelson S, Barclay P. Demyelinating neuropathy
       accompanying Lyme disease. Neurology 1982; 32:1302-1305.

           Complimentary Contributor Copy
   91   92   93   94   95   96   97   98   99   100   101